About Eurekam
Eurekam is a company based in Lagord (France) founded in 2012 by Loic Tamarelle and Benoit Le Franc. Eurekam has raised $8.84 million across 3 funding rounds from investors including Bpifrance, Impact Partners and Sofimac Investment Managers. Eurekam offers products and services including Drugcam Oncology and Drugcam Vaccine. Eurekam operates in a competitive market with competitors including House Rx, DecisionRx, GalenusRx, Prescription Advisory Systems & Technology and Pillcheck, among others.
- Headquarter Lagord, France
- Founders Loic Tamarelle, Benoit Le Franc
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.84 M (USD)
in 3 rounds
-
Latest Funding Round
$6.34 M (USD), Series B
Oct 05, 2022
-
Investors
Bpifrance
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eurekam
Eurekam offers a comprehensive portfolio of products and services, including Drugcam Oncology and Drugcam Vaccine.
Ensures accurate preparation of cancer chemotherapy drugs
Facilitates safe production of vaccine doses
Funding Insights of Eurekam
Eurekam has successfully raised a total of $8.84M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $6.34 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Eurekam
Eurekam has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Bpifrance, Impact Partners and Sofimac Investment Managers.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Early to Growth stage VC & PE firm funding
|
Locked | Locked | Locked | |
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for Eurekam
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Eurekam
Investment portfolio details for Eurekam
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Eurekam
Detailed financials for Eurekam
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eurekam Comparisons
Peer comparison for Eurekam
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Eurekam
Eurekam operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as House Rx, DecisionRx, GalenusRx, Prescription Advisory Systems & Technology and Pillcheck, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Technology-based medication solutions are provided for patients and caregivers.
|
|
| Locked | Locked | Locked |
Medication management solutions are provided to patients and healthcare providers.
|
|
| Locked | Locked | Locked |
Medication safety risk management solutions are provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Software for Doctors to Help Treat Pain & Reduce Abuse of Controlled Substances
|
|
| Locked | Locked | Locked |
DNA testing platform for user medication responses is offered.
|
Detailed competitors of Eurekam
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eurekam
Complete news archive for Eurekam
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eurekam
Eurekam was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Eurekam is headquartered in Lagord, France. It is registered at Lagord, Charente-maritime, France.
Eurekam is a funded company, having raised a total of $8.84M across 3 funding rounds to date.
Eurekam was founded in 2012 in Lagord, France, as a provider of medication management solutions in the oncology sector. An AI-based platform called DRUGCAM is offered, which uses video to prevent errors in chemotherapy treatments through monitoring of active substances, administration methods, and dosages for real-time validation. Additional tools support documentation of drug preparations and therapy management for clinical optimization.
Eurekam's top competitors include House Rx, DecisionRx and GalenusRx.
Eurekam offers Drugcam Oncology and Drugcam Vaccine.
Eurekam has 6 investors. Key investors include Bpifrance, Impact Partners, Sofimac Investment Managers, Aquiti Gestion, and FIP - International Pharmaceutical Federation.